Dermolution Trend Reshapes Skincare with Science-Backed Solutions

A growing skincare trend called dermolution is gaining attention. It focuses on strengthening the skin’s microbiome and barrier for long-term health. Consumers are now seeking medically backed products that deliver visible, science-based results. Dermolution prioritises therapeutic, evidence-based solutions over passing fads. Followers of the trend demand transparency about ingredients and their effects. This shift has boosted brands offering clinical, dermatologist-approved formulations.

Clinical skincare brands already held 33% of the market in 2020. Their share grew by 3% in the past year, partly driven by influencer endorsements. Social media figures known as ‘skintellectuals’ and ‘skinfluencers’ promote products with proven efficacy.

Micropeeling has emerged as a leading non-surgical treatment for anti-ageing. It ranks as the second most popular procedure of its kind worldwide. A natural active called ApibreezeTM is now being added to these products to meet dermolution standards.

ApibreezeTM causes less irritation than traditional peels. Tests show it triggers no inflammatory response while improving hydration and collagen production in vitro. Its gentle yet effective action aligns with the trend’s focus on skin barrier repair. The demand for micropeeling and science-backed actives like ApibreezeTM reflects a broader consumer push for transparency and performance. Clinical brands and dermatological solutions continue to expand their market presence as the dermolution trend strengthens.